促红细胞生成素联合或不联合粒细胞集落刺激因子（G-CSF）治疗骨髓增生异常综合征（MDS）患者。 - Suppr

Suppr

超能文献

Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients.

作者信息

Miller K

机构信息

New England Medical Center, Boston, MA 02111, USA.

出版信息

Leuk Res. 1998 May;22 Suppl 1:S13-6. doi: 10.1016/s0145-2126(98)00035-6.

DOI:10.1016/s0145-2126(98)00035-6

PMID:9734694

Abstract

摘要

相似文献

Erythropoietin, with and without granulocyte-colony stimulating factor (G-CSF), in the treatment of myelodysplastic syndrome (MDS) patients.促红细胞生成素联合或不联合粒细胞集落刺激因子（G-CSF）治疗骨髓增生异常综合征（MDS）患者。

Leuk Res. 1998 May;22 Suppl 1:S13-6. doi: 10.1016/s0145-2126(98)00035-6.

Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes.

Haematologica. 1999 Dec;84(12):1057.

Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromes.

Ann Hematol. 1994 Apr;68(4):163-6. doi: 10.1007/BF01834360.

[Effect of recombinant human G-CSF combined with EPO in treatment of patients with MDS].

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Jun;13(3):512-3.

Revisiting the use of recombinant erythropoietin in myelodysplastic syndromes.重新审视重组促红细胞生成素在骨髓增生异常综合征中的应用。

Clin Lymphoma. 2005 Jun;6(1):52-5. doi: 10.3816/clm.2005.n.029.

Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges.

Blood. 2004 Oct 1;104(7):2201; author reply 2201-2. doi: 10.1182/blood-2004-04-1334.

Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.重组人粒细胞集落刺激因子和促红细胞生成素长期给药治疗骨髓增生异常综合征中的贫血

Br J Haematol. 2000 May;109(2):367-75. doi: 10.1046/j.1365-2141.2000.02016.x.

Dramatic hyperleukocytosis after treatment of myelodysplastic syndrome with pegfilgrastim and darbepoetin-alfa.

Ann Hematol. 2008 Jan;87(1):77-8. doi: 10.1007/s00277-007-0364-9. Epub 2007 Aug 21.

A strategy for erythropoietin treatment in myelodysplastic syndromes.骨髓增生异常综合征中促红细胞生成素治疗策略

Med Oncol. 1999 Sep;16(3):188-90. doi: 10.1007/BF02906130.

Unusual clinical presentation in a patient with myelodysplastic syndrome, with subsequent hematological remission and suppression of the malignant clone following treatment with cyclosporine A, erythropoietin and granulocyte colony-stimulating factor.一名骨髓增生异常综合征患者出现不寻常的临床表现，随后在接受环孢素A、促红细胞生成素和粒细胞集落刺激因子治疗后出现血液学缓解并抑制了恶性克隆。

Leuk Res. 1999 May;23(5):513-7. doi: 10.1016/s0145-2126(99)00038-7.

引用本文的文献

Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes.粒细胞和粒细胞巨噬细胞集落刺激因子用于新诊断的骨髓增生异常综合征患者。

Cochrane Database Syst Rev. 2016 Feb 16;2(2):CD009310. doi: 10.1002/14651858.CD009310.pub2.

The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002).骨髓增生异常综合征：形态学、风险评估及临床管理（2002年）

Int J Hematol. 2002 Aug;76 Suppl 2:228-38. doi: 10.1007/BF03165122.

Myelodysplastic syndromes.骨髓增生异常综合征

Curr Treat Options Oncol. 2000 Apr;1(1):63-9. doi: 10.1007/s11864-000-0016-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验